AlzoSure Predict
Pre-clinical- Indications
- Alzheimer's disease
Company intelligence / Profile preview
Diadem
Milan, Italydiademdx.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Preclinical
01
Overview
Diadem has developed AlzoSure Predict, a proprietary blood-based diagnostic test that uses an antibody to detect a specific conformation of the p53 protein associated with early Alzheimer’s disease. The test can predict progression to Alzheimer’s up to six years before symptoms appear. It is CE-IVD marked in Europe and has received FDA Breakthrough Device Designation. Initial clinical studies have shown high sensitivity and specificity for predicting cognitive decline and Alzheimer's onset. Large retrospective and prospective trials are underway for further validation.
- Therapeutic areas
- Neurology
- Modalities
- AntibodyDiagnostic assay
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
University of Brescia (originating research center)
Beyond the preview
Go deeper on Diadem.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diadem.